Osteochondrodystrophic Lesions in Chelated Thalassemic Patients: An Histological Analysis


Some patients affected by thalassemia major and treated with an iron-chelating drug such as deferioxamine can suffer from severe osteochondrodystrophic lesions of the long bones. These lesions were radiologically and clinically evident in 2.8% of the patients we examined over the last 10 years. The aim of our research was to evaluate the morphology and… (More)
DOI: 10.1007/s00223001121


8 Figures and Tables

Slides referencing similar topics